Bristol-Myers Squibb Company
BMY
$59.01
-$1.27-2.11%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
--
EPS (TTM)
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -8.95B | -7.26B | -6.54B | -6.15B | 8.03B |
| Total Depreciation and Amortization | 9.58B | 10.18B | 10.02B | 9.84B | 9.77B |
| Total Amortization of Deferred Charges | 0.00 | 0.00 | 0.00 | 28.00M | -- |
| Total Other Non-Cash Items | 13.75B | 11.70B | 11.72B | 10.36B | -2.02B |
| Change in Net Operating Assets | 810.00M | 389.00M | -1.03B | -356.00M | -1.91B |
| Cash from Operations | 15.19B | 15.00B | 14.16B | 13.72B | 13.86B |
| Capital Expenditure | -1.25B | -1.20B | -1.22B | -1.22B | -1.21B |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -21.82B | -22.36B | -22.33B | -21.14B | -1.17B |
| Divestitures | 1.10B | 1.01B | 999.00M | 923.00M | 909.00M |
| Other Investing Activities | 618.00M | 46.00M | -141.00M | -267.00M | -826.00M |
| Cash from Investing | -21.35B | -22.50B | -22.69B | -21.70B | -2.30B |
| Total Debt Issued | 15.97B | 20.60B | 20.49B | 20.28B | 4.46B |
| Total Debt Repaid | -5.87B | -7.99B | -5.25B | -2.36B | -4.00B |
| Issuance of Common Stock | -- | 25.00M | 27.00M | 27.00M | 27.00M |
| Repurchase of Common Stock | -- | 0.00 | -4.00B | -4.91B | -5.16B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -4.86B | -4.81B | -4.78B | -4.76B | -4.74B |
| Other Financing Activities | -106.00M | -87.00M | -64.00M | -5.00M | 0.00 |
| Cash from Financing | 5.13B | 7.74B | 6.43B | 8.28B | -9.42B |
| Foreign Exchange rate Adjustments | -137.00M | 88.00M | -27.00M | -13.00M | 45.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.17B | 325.00M | -2.13B | 286.00M | 2.19B |
